References
- Agarwal SK, Reveille JD. The genetics of scleroderma (systemic sclerosis). Curr. Opin. Rheumatol.22(2), 133–138 (2010).
- Barcellos LF, Kamdar BB, Ramsay PP et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol.5, 924–931 (2006).
- Tait KF, Marshall T, Berman J et al. Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository. Diabet. Med.21, 358–362 (2004).
- Hindorff LA, Sethupathy P, Junkins HA et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 2009 106(23), 9362–9367 (2009).
- Baranzini SE. The genetics of autoimmune diseases: a networked perspective. Curr. Opin. Immunol.21(6), 596–605 (2009).
- Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with Type I diabetes. Nat. Genet.36(4), 337–338 (2004).
- Diaz-Gallo L, Gourh P, Broen J et al. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann. Rheum. Dis.70(3), 454–462 (2010).
- Radstake TR, Gorlova O, Rueda B et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet.42(5), 426–429 (2010).
- Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet.11(12), 843–854 (2010).
Website
- A catalog of published genome-wide association studies www.genome.gov/26525384